Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by André Delannoy
The Clinical Relevance of Imatinib Plasma Trough Concentrations in Chronic Myeloid Leukemia. A Belgian Study
Clinical Biochemistry
Medicine
Clinical Biochemistry
Related publications
Influence of CYP3A5 and Drug Transporter Polymorphisms on Imatinib Trough Concentration and Clinical Response Among Patients With Chronic Phase Chronic Myeloid Leukemia
Journal of Human Genetics
Genetics
Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?
ISRN Oncology
The Development of Imatinib as a Therapeutic Agent for Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Recommendations for Clinical Practice From the French Chronic Myeloid Leukemia Study Group
Cancer
Cancer Research
Oncology
Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells
PLoS ONE
Multidisciplinary
